Skip to main content
. 2012 Jul 11;2012(7):CD006534. doi: 10.1002/14651858.CD006534.pub2

Akimova 2011.

Methods Double‐blind, longitudinal study.
Participants Patients with MDD.
Interventions Citalopram: 20mg/day.
Escitalpram: 10mg/day.
Outcomes Alterations in different brain regions assessed with PET scans using the radioligand [11C]DASB.
Notes